Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1942
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorPimenta, Ruanen_US
dc.contributor.authorCamargo, Juliana A.en_US
dc.contributor.authorCandido,, Patríciaen_US
dc.contributor.authorGhazarian, Vitóriaen_US
dc.contributor.authorGonçalves, Guilherme L.en_US
dc.contributor.authorGuimarães, Vanessa R.en_US
dc.contributor.authorRomão, Polianaen_US
dc.contributor.authorChiovatto, Carolineen_US
dc.contributor.authorMioshia, Carolina M.en_US
dc.contributor.authorSantos, Gabriel A. dosen_US
dc.contributor.authorBirbrairf, Alexanderen_US
dc.contributor.authorSrougia, Miguelen_US
dc.contributor.authorNahas, William C.en_US
dc.contributor.authorLeite, Kátia R.en_US
dc.contributor.authorViana, Nayara I.en_US
dc.contributor.authorReis, Sabrina T.en_US
dc.date.accessioned2024-08-30T15:04:08Z-
dc.date.available2024-08-30T15:04:08Z-
dc.date.issued2022-
dc.identifier.citationPimenta, Ruan , et al. “Cholesterol triggers nuclear co-association of androgen receptor, p160 steroid coactivators, and p300/CBP- associated factor leading to androgenic axis rransactivation in castration-resistant prostate cancer”. Cellular Physiology and Biochemistry, vol. 56, no S4, dezembro de 2022, p. 1–15.en_US
dc.identifier.issn1421-9778-
dc.identifier.urihttp://repo.saocamilo-sp.br:8080/jspui/handle/123456789/1942-
dc.description.abstractBackground/Aims: Cholesterol modulates intratumoral androgenic signaling in prostate cancer; however, the molecular mechanisms underlying these changes in castration-resistant prostate cancer (CRPC) are not fully elucidated. Herein, we investigated the effect of cholesterol on androgen receptor (AR) coactivators expression and tumorigenesis in vitro and in vivo. Methods: Herein, we monitored the expression of AR coactivators (SRC-1, 2, 3 and PCAF) genes in PC-3 cells exposed to 2µg/mL of cholesterol for 8 hours by qPCR. We also performed cell migration at 0, 8, 24, 48 and 72h and flow cytometry assays (viability, apoptosis, and cell cycle) after a 24h exposure. Immunofluorescence assay was performed to evaluate the protein expression of the AR coactivators. Additionally, in vivo experiments were conducted using 22 male NOD/SCID mice. Mice were fed a standard (Control) or hypercholesterolemic (HCOL) diet for 21 days and then subcutaneously implanted with PC-3 cells. The tumor volume was calculated every two days, and after four weeks, the tumors were resected, weighed, and the serum lipid profile was measured. We also measured the intratumoral lipid profile and AR coactivators gene and protein expression by qPCR and Western Blot, respectively. Intratumor testosterone and dihydrotestosterone (DHT) concentrations were determined using ELISA. Results: Cholesterol up-regulated the gene expression of coactivators SRC-1, SRC-2, SRC-3 and PCAF, increasing AR expression in PC-3 cells. Next, cholesterol-supplemented PC-3 cells exhibited increased cell migration and altered cell cycle phases, leading to changes in proliferation and reduced apoptosis. We found that SRC-1, SRC-2, SRC-3 and PCAF proteins co-localized in the nucleus of cholesterol-supplemented cells and co-associate with AR. In the in vivo model, the hypercholesterolemic (HCOL) group displayed higher serum total and intratumoral cholesterol levels, increased testosterone and dihydrotestosterone concentrations, and up-regulated AR coactivator expression. The tumor volume of the HCOL group was significantly higher than the control group. Conclusion: Our findings revealed that increased nuclear translocation of the coactivators leads to up-regulated AR gene and protein expression, potentially influencing tumor progression. Studies targeting cholesterol modulated changes in AR coactivator expression may provide insights into the molecular mechanisms associated with the CRPC phenotype.-
dc.publisherInternational Journal of Experimental Cellular Physiology, Biochemistry and Pharmacologyen_US
dc.relation.ispartofCellular physiology and biochemistry, v. 56, S4, 2022, p. 1-15en_US
dc.subjectNeoplasias da próstataen_US
dc.titleCholesterol triggers nuclear co-association of androgen receptor, p160 steroid coactivators, and p300/CBP - associated factor leading to androgenic axis transactivation in castration-resistant prostate canceren_US
dc.typeArtigo de Periódicoen_US
dc.identifier.doi10.33594/000000592-
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Arquivo TamanhoFormato 
Caroline Chiovatto - Cholesterol Triggers Nuclear Co-Association of Androgen Recepto.pdf2.5 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.